Long-read genomic data¶
Genomics England, in partnership with the Sanger Institute and Pacific Biosciences amongst others, has been assessing the advantages of long-reads sequencing technologies over Illumina short-reads whole genome sequencing. To this end, we have employed both Oxford Nanopore Technologies and Pacific Biosciences methodologies.
Upon availability of the data and/or expiration of potential embargoes we aim to provide researchers access to this data.
A separate section has been made available in LabKey as of 100kGP Data Release v17 containing various tables related to long read sequencing data.
Datasets available¶
Dataset | Technology | Project | Type | Summary | Participant count | Data types | Data location | Tables |
---|---|---|---|---|---|---|---|---|
ONT rare disease pilot | Oxford Nanopore | 100kGP | Rare disease | First ONT data set with structural variant calls | 315 | Regular BAMs Structural variants |
/gel_data_resources/LRS_cohort_genomes/Rare_Disease/ |
LabKey rare_disease_ont_cohorts |
ONT cancer pilot | Oxford Nanopore | 100kGP | Cancer | First ONT data set generated for 100kGP cancer participants and first data set with methylation calls | 100 | Regular BAMs Methyl BAMs |
/gel_data_resources/LRS_cohort_genomes/cohort_CML |
LabKey cancer_ont_cohorts |
PacBio rare disease pilot | PacBio | 100kGP | Rare disease | Example dataset to demonstrate the utility of PacBio's HiFi technology | 91 | Small variants Structural variants |
/gel_data_resources/LRS_genomes/WGS_PacBio |
LabKey rare_disease_pacbio_pilot |
ONT pilot | Oxford Nanopore | 100kGP | Rare disease | First ONT data set generated for 100kGP participants | 47 | Raw sequencing data (FAST5) FASTQ Regular BAMs |
/gel_data_resources/LRS_genomes/WGS_ONT/ |
LabKey lrs_laboratory_sample and lrs_sequencing_data |
ONT COVID-19 | Oxford Nanopore | COVID-19 | Mild and severely affected COVID-19 participants | 191 | Structural variants HLA genotyping |
CloudOS GEL genomes > covid-19 > oxford_nanopore |
linking_table_covid_ont.tsv |